This inventor holds 9 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Eli Lilly and Company, Baylor College of Medicine, Johns Hopkins University. Active years: 2001-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Indianapolis, IN (US) (2001 - 2010)
- Fishers, IN (US) (2003 - 2014)
Company Filing History:
5 out of 4,517 
2 out of 619 
2 out of 3,803 
Years Active: 2001-2014
Title: The Innovative Mind of Venkatesh Krishnan: Pioneering Patents in Androgen Receptor Modulation
Introduction: Venkatesh Krishnan, based in Fishers, IN, is a notable inventor with a remarkable portfolio of 9 patents to his name. His work primarily revolves around the field of selective androgen receptor modulators, contributing significantly to the pharmaceutical industry.
Latest Patents: One of Krishnan's latest patents is focused on "4-aminobenzonitrile selective androgen receptor modulators." This invention introduces novel selective androgen receptor modulators along with their salts and pharmaceutical compositions. Another significant patent of his is for "Tetrahydrocyclopenta[b]indole androgen receptor modulators." This invention outlines a compound that offers valuable applications in treating or preventing physiological disorders, including conditions like reduced bone mass, osteoporosis, and erectile dysfunction through specific pharmaceutical compositions.
Career Highlights: Throughout his career, Venkatesh Krishnan has worked with renowned companies, including Eli Lilly and Company. His contributions in the field have been instrumental, positioning him as a leading inventor in his area of specialization.
Collaborations: Krishnan has collaborated with notable coworkers such as Ming-Jer Tsai and Sophia Yang Tsai. Their collective efforts reflect a commitment to innovation and excellence in their research endeavors.
Conclusion: Venkatesh Krishnan's contributions to the field of selective androgen receptor modulation are significant and impactful. With multiple patents bearing his name, he continues to advance pharmaceutical science, showcasing the importance of innovation in addressing critical health issues. His journey exemplifies the spirit of invention and the collaborative nature of research in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile